Comparación de costes por eventos en los que incurre un paciente con síndrome coronario agudo suministrándole los fármacos prasugrel vs. clopidogrel [PDF]
Comparación de costes por eventos generados en pacientes con un SCA, una vez suministrados los fármacos prasugrel o clopidogrel. Se analizan los costes en los que incurre un paciente durante un período de 455 días/15 meses aproximadamente y se evalúan ...
Loredo Blanco, Sulkari +1 more
core
Current concepts on coronary revascularization in diabetic patients [PDF]
Diabetic mellitus (DM) patients with coronary artery disease (CAD) are at higher risk of cardiovascular events compared with non-DM individuals. While aggressive cardiovascular prevention and adequate blood glucose control remain cornerstones of therapy,
Angiolillo, Dominick J. +2 more
core
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention [PDF]
Although platelet reactivity during P2Y12-inhibitors is associated with stent thrombosis (ST) and bleeding, standardized and clinically validated thresholds for accurate risk stratification after percutaneous coronary intervention (PCI) are lacking.
Aradi, Dániel
core
Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, JapanCorrespondence: Keiko ...
Kozaru M +4 more
doaj
Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty. [PDF]
Jia K +4 more
europepmc +1 more source
Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus [PDF]
Parker, W.A.E., Storey, R.F.
core +1 more source
Efficacy and safety of off-label low-dose compared with standard-dose antiplatelet agents in patients with coronary heart disease: a meta-analysis. [PDF]
Zheng L +11 more
europepmc +1 more source
Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]
Navarese EP +12 more
europepmc +1 more source

